9 participants
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-20
- Start Date:
- 2021-11-05
- Completion:
- 2024-11-05
Conditions
- Immune Nephritis
- Autoimmune Diseases
- Lupus Nephritis
Interventions
- BIOLOGICAL
No Results Yet